CoChat

Temporal Trend in Young-Onset Type 2 Diabetes—Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records

Koye, Digsu N., Ling, Joanna, Dibato, John, Khunti, Kamlesh, Montvida, Olga, Paul, Sanjoy K. · 2020 · Diabetes Care
Cited by 41

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate temporal prevalence trend, cardiometabolic risk factors, and the risk of atherosclerotic cardiovascular disease (ASCVD) and all-cause mortality (ACM) in incident young- and usual-onset type 2 diabetes. RESEARCH DESIGN AND METHODS: From the U.K. primary care database, 370,854 people with a new diagnosis of type 2 diabetes from 2000 to 2017 were identified. Analyses were conducted by age- group (18–39, 40–49, 50–59, 60–69, 70–79 years) and high-/low-risk status without history of ASCVD at diagnosis, with subjects with two or more of current smoking, high systolic blood pressure, high LDL cholesterol (LDL-C), or chronic kidney disease classified as high risk. RESULTS: The proportion of people aged <50 years at diagnosis increased during 2000–2010 and then stabilized. The incidence rates of ASCVD and ACM declined in people aged ≥50 years but did not decrease in people <50 years. Compared with people aged ≥50 years, those aged 18–39 years at diagnosis had a higher proportion of obesity (71% obese) and higher HbA1c (8.6%), and 71% had high LDL-C, while only 18% were on cardioprotective therapy. Although 2% in this age-group had ASCVD at diagnosis, 23% were identified as high risk. In the 18–39-year age-group, the adjusted average years to ASCVD/ACM in high-risk individuals (9.1 years [95% CI 8.2–10.0]/9.3 years [8.1–10.4]) were similar to the years in those with low risk (10.0 years [9.5–10.5]/10.5 years [9.7–11.2]). However, individuals aged ≥50 years with high risk were likely to experience an ASCVD event 1.5–2 years earlier and death 1.1–1.5 years earlier compared with low-risk groups (P < 0.01). CONCLUSIONS: Unlike usual-onset, young-onset type 2 diabetes has similar cardiovascular and mortality risk irrespective of cardiometabolic risk factor status at diagnosis. The guidelines on the management of young-onset type 2 diabetes for intensive risk factor management and cardioprotective therapies need to be urgently reevaluated through prospective studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc20-0417

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Geiss, 2014, Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012, JAMA, 312, 1218, 10.1001/jama.2014.11494 · DOI · Paper page
  2. Dabelea, 2017, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood, JAMA, 317, 825, 10.1001/jama.2017.0686 · DOI · Paper page
  3. Steinarsson, 2018, Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register, Diabetologia, 61, 599, 10.1007/s00125-017-4532-8 · DOI · Paper page
  4. Mayer-Davis, 2017, Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012, N Engl J Med, 376, 1419, 10.1056/NEJMoa1610187 · DOI · Paper page
  5. Ke, 2019, Excess burden of mental illness and hospitalization in young-onset type 2 diabetes, Ann Intern Med, 171, 78, 10.7326/L19-0243 · DOI
  6. Huo, 2018, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011, Diabetologia, 61, 1055, 10.1007/s00125-018-4544-z · DOI · Paper page
  7. Koye, 2019, Trends in incidence of ESKD in people with type 1 and type 2 diabetes in Australia, 2002-2013, Am J Kidney Dis, 73, 300, 10.1053/j.ajkd.2018.10.005 · DOI
  8. Hillier, 2003, Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth, Diabetes Care, 26, 2999, 10.2337/diacare.26.11.2999 · DOI · Paper page
  9. Denburg, 2011, Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease, Pharmacoepidemiol Drug Saf, 20, 1138, 10.1002/pds.2203 · DOI
  10. Blak, 2011, Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates, Inform Prim Care, 19, 251
  11. Mulnier, 2006, Mortality in people with type 2 diabetes in the UK, Diabet Med, 23, 516, 10.1111/j.1464-5491.2006.01838.x · DOI · Paper page
  12. Owusu Adjah, 2018, Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis, Cardiovasc Diabetol, 17, 70, 10.1186/s12933-018-0712-1 · DOI
  13. Owusu Adjah, 2017, Data mining approach to identify disease cohorts from primary care electronic medical records: a case of diabetes mellitus, Open Bioinform J, 10, 16, 10.2174/1875036201710010016 · DOI
  14. Owusu Adjah, 2019, Ethnicity-specific association of BMI levels at diagnosis of type 2 diabetes with cardiovascular disease and all-cause mortality risk, Acta Diabetol, 56, 87, 10.1007/s00592-018-1219-7 · DOI
  15. Read, 1991, The Read clinical classification (Read codes), Br Homeopath J, 80, 14, 10.1016/S0007-0785(05)80418-1 · DOI
  16. Sharma, 2016, An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database, Clin Epidemiol, 8, 373, 10.2147/CLEP.S113415 · DOI · Paper page
  17. Read, 2018, Performance of cardiovascular disease risk scores in people diagnosed with type 2 diabetes: external validation using data from the National Scottish Diabetes Register, Diabetes Care, 41, 2010, 10.2337/dc18-0578 · DOI · Paper page
  18. Gong, 2017, Estimating the average treatment effect on survival based on observational data and using partly conditional modeling, Biometrics, 73, 134, 10.1111/biom.12542 · doi:10.1111/biom.12542
  19. Magliano, 2019, Trends in incidence of total or type 2 diabetes: systematic review, BMJ, 366, l5003, 10.1136/bmj.l5003 · DOI · Paper page
  20. Song, 2015, Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population, BMJ Open Diabetes Res Care, 3, e000044, 10.1136/bmjdrc-2014-000044 · DOI · Paper page
  21. TODAY Study Group, 2013, Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial, Diabetes Care, 36, 1735, 10.2337/dc12-2420 · DOI · Paper page
  22. Ke, 2020, Cardiovascular outcomes trials in type 2 diabetes: time to include young adults, Diabetes Obes Metab, 22, 3, 10.1111/dom.13874 · DOI · Paper page
  23. Luk, 2017, Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: the Hong Kong diabetes database, Diabetes Care, 40, 928, 10.2337/dc16-2354 · DOI · Paper page
  24. Harding, 2014, Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010, Diabetes Care, 37, 2579, 10.2337/dc14-0096 · DOI · Paper page
  25. Thomas, 2014, Statistical challenges in analysing large longitudinal patient-level data: the danger of misleading clinical inferences with imputed data, J Indian Soc Agric Stat, 68, 39

Cited by

See all 41

Metadata

Authors
Koye, D. N., Ling, J., Dibato, J., Khunti, K., Montvida, O., & Paul, S. K.
Affiliations
  • Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia
  • Department of Health Sciences, University of Leicester, Leicester, U.K.
Venue
Diabetes Care
Published
2020-07-02
Volume
43
Issue
9
Pages
2208-2216
ISSN
  • 0149-5992
  • 1935-5548
Cited by
41
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.